tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rhythm Biosciences Announces Quotation of New Securities on ASX

Story Highlights
Rhythm Biosciences Announces Quotation of New Securities on ASX

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Rhythm Biosciences Ltd. ( (AU:RHY) ) just unveiled an update.

Rhythm Biosciences Ltd. announced the application for quotation of 38,321,133 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions, potentially enhancing the company’s capital structure and market presence, which could have implications for its strategic growth and stakeholder value.

More about Rhythm Biosciences Ltd.

Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development and commercialization of medical diagnostics. The company is primarily engaged in creating innovative diagnostic solutions aimed at early detection and monitoring of cancer, with a significant market focus on improving patient outcomes through advanced technology.

Average Trading Volume: 744,118

Technical Sentiment Signal: Buy

Current Market Cap: A$30.54M

Learn more about RHY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1